Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?

CD44, MMP-2, and MMP-9 are new potential molecular prognostic markers in renal cell carcinoma (RCC). The aim of the study was to analyze whether the expression of CD44, MMP-2, and MMP-9 in association with the histopathological subtype of RCC affects the survival of patients with renal cancer. The s...

Full description

Bibliographic Details
Main Authors: Magdalena Chrabańska, Magdalena Rynkiewicz, Paweł Kiczmer, Bogna Drozdzowska
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/4/1202
_version_ 1797621897543811072
author Magdalena Chrabańska
Magdalena Rynkiewicz
Paweł Kiczmer
Bogna Drozdzowska
author_facet Magdalena Chrabańska
Magdalena Rynkiewicz
Paweł Kiczmer
Bogna Drozdzowska
author_sort Magdalena Chrabańska
collection DOAJ
description CD44, MMP-2, and MMP-9 are new potential molecular prognostic markers in renal cell carcinoma (RCC). The aim of the study was to analyze whether the expression of CD44, MMP-2, and MMP-9 in association with the histopathological subtype of RCC affects the survival of patients with renal cancer. The study population included 243 clear cell RCC (ccRCC) and 59 non-ccRCC cases. A total of 302 tumors were examined for CD44, MMP2, and MMP9 expression by immunohistochemistry. The expression levels of the proteins were scored by semi-quantitative methods, and the correlation with overall patient survival was verified. We found no significant differences in CD44 expression levels between cc-RCC and non-ccRCC cases; however, significant differences existed in the degree of MMP-2 and MMP-9 expression between cc-RCC and non-ccRCC cases. There was significantly higher MMP expression in non-ccRCC than in ccRCC cases. Univariate Cox regression analysis showed that increased CD44 expression and histopathological subtype of ccRCC were predictors of shorter overall survival. Moreover, MMP-2 overexpression slightly reduced the risk of patient death, while MMP-9 expression did not show an association with patients’ survival. However, on multivariate analysis, only the histopathological subtypes of ccRCC and CD44 expression were independent risk factors for patient death.
first_indexed 2024-03-11T09:02:30Z
format Article
id doaj.art-ed90ee308f7441b0a567f7ad2b396206
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T09:02:30Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-ed90ee308f7441b0a567f7ad2b3962062023-11-16T19:37:45ZengMDPI AGCancers2072-66942023-02-01154120210.3390/cancers15041202Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?Magdalena Chrabańska0Magdalena Rynkiewicz1Paweł Kiczmer2Bogna Drozdzowska3Department and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandDepartment and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandDepartment and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandDepartment and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandCD44, MMP-2, and MMP-9 are new potential molecular prognostic markers in renal cell carcinoma (RCC). The aim of the study was to analyze whether the expression of CD44, MMP-2, and MMP-9 in association with the histopathological subtype of RCC affects the survival of patients with renal cancer. The study population included 243 clear cell RCC (ccRCC) and 59 non-ccRCC cases. A total of 302 tumors were examined for CD44, MMP2, and MMP9 expression by immunohistochemistry. The expression levels of the proteins were scored by semi-quantitative methods, and the correlation with overall patient survival was verified. We found no significant differences in CD44 expression levels between cc-RCC and non-ccRCC cases; however, significant differences existed in the degree of MMP-2 and MMP-9 expression between cc-RCC and non-ccRCC cases. There was significantly higher MMP expression in non-ccRCC than in ccRCC cases. Univariate Cox regression analysis showed that increased CD44 expression and histopathological subtype of ccRCC were predictors of shorter overall survival. Moreover, MMP-2 overexpression slightly reduced the risk of patient death, while MMP-9 expression did not show an association with patients’ survival. However, on multivariate analysis, only the histopathological subtypes of ccRCC and CD44 expression were independent risk factors for patient death.https://www.mdpi.com/2072-6694/15/4/1202CD-44MMP-2MMP-9renal cell carcinomaimmunohistochemistry
spellingShingle Magdalena Chrabańska
Magdalena Rynkiewicz
Paweł Kiczmer
Bogna Drozdzowska
Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
Cancers
CD-44
MMP-2
MMP-9
renal cell carcinoma
immunohistochemistry
title Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
title_full Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
title_fullStr Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
title_full_unstemmed Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
title_short Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
title_sort does the immunohistochemical expression of cd44 mmp 2 and mmp 9 in association with the histopathological subtype of renal cell carcinoma affect the survival of patients with renal cancer
topic CD-44
MMP-2
MMP-9
renal cell carcinoma
immunohistochemistry
url https://www.mdpi.com/2072-6694/15/4/1202
work_keys_str_mv AT magdalenachrabanska doestheimmunohistochemicalexpressionofcd44mmp2andmmp9inassociationwiththehistopathologicalsubtypeofrenalcellcarcinomaaffectthesurvivalofpatientswithrenalcancer
AT magdalenarynkiewicz doestheimmunohistochemicalexpressionofcd44mmp2andmmp9inassociationwiththehistopathologicalsubtypeofrenalcellcarcinomaaffectthesurvivalofpatientswithrenalcancer
AT pawełkiczmer doestheimmunohistochemicalexpressionofcd44mmp2andmmp9inassociationwiththehistopathologicalsubtypeofrenalcellcarcinomaaffectthesurvivalofpatientswithrenalcancer
AT bognadrozdzowska doestheimmunohistochemicalexpressionofcd44mmp2andmmp9inassociationwiththehistopathologicalsubtypeofrenalcellcarcinomaaffectthesurvivalofpatientswithrenalcancer